Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers

Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers

ObjectivesWe aimed to examine clinical data and baseline blood test results as potential predictive biomarkers for benefit from nivolumab, in advanced non-small cell lung cancer patients (NSCLC).Materials and MethodsA chart review was performed of 108 advanced NSCLC patients who commenced treatment...

Full description

Bibliographic Details
Main Authors: Sameh Daher, Yaacov R. Lawrence, Elizabeth Dudnik, Ekaterina Hanovich, Damien Urban, Nir Peled, Rossie Navon, Raya Leibowitz, Ariel Hammerman, Erez Battat, Teodor Gottfried, Amir Onn, Jair Bar
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
nivolumab
NSCLC
long term survival
real life data
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.625668/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.625668/full

Similar Items